RxDoctor Payments Data

Logan Shockley

Family · Rolla, MONPI 1295374148

Payments from drug & device makers

$4,008in general payments, 2019–2025

Across 182 payments — averaging $22.02 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novartis$418
  • Johnson & Johnson$392
  • AstraZeneca$341
  • Incyte Corporation$328
  • Novocure GmbH$250
  • Daiichi Sankyo Inc.$246
  • plus $2K from 34 others

What the payments were for

  • Speaking & faculty fees$2506%
  • Food & beverage$3,70492%
  • Education$541%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$4,008 in reported general payments places this provider in the 90th percentile of 3,812 family providers in Missouri.

See all family providers in Missouri

Medicare billing

Part B allowed, 2024
$68,465
Medicare patients
276
Services billed
629

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban23$19,474
XareltoRivaroxaban14$14,887
Raloxifene Hcl20$955
Prochlorperazine Maleate28$903
Ondansetron Hcl14$595
Anastrozole47$566
Gabapentin43$538
Omeprazole45$520
Hydroxyurea17$454
Potassium Chloride31$303
Letrozole15$252
Lidocaine-PrilocaineLidocaine/Prilocaine17$211
Dexamethasone28$187
Triamcinolone Acetonide25$163
Levothyroxine Sodium13$77

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$107$19,47423 claims
Johnson & JohnsonXarelto$392$14,88714 claims
Lilly USA, LLCOlanzapine$36$6225 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 3,812 family providers in Missouri.

Other family in Rolla

See the full list for Missouri

Where these figures come from

Is this you, or does something look wrong? →